STATE STREET CORP - CANDEL THERAPEUTICS INC ownership

CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 21 filers reported holding CANDEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of CANDEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25,668
-26.2%
27,6000.0%0.00%
Q2 2023$34,776
-8.0%
27,6000.0%0.00%
Q1 2023$37,812
-61.7%
27,600
-50.0%
0.00%
Q4 2022$98,808
+13.6%
55,200
+100.0%
0.00%
Q3 2022$87,000
-2.2%
27,6000.0%0.00%
Q2 2022$89,000
-36.4%
27,6000.0%0.00%
Q1 2022$140,000
-32.7%
27,600
+3.8%
0.00%
Q4 2021$208,000
-27.8%
26,6000.0%0.00%
Q3 2021$288,00026,6000.00%
Other shareholders
CANDEL THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Northpond Ventures, LLC 1,935,215$1,780,3985.13%
Sands Capital Ventures, LLC 811,737$746,7980.22%
Empirical Asset Management, LLC 10,000$9,2000.01%
Baystate Wealth Management LLC 97,310$89,5250.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,595$123,3130.00%
FRANKLIN RESOURCES INC 1,125,000$1,046,2500.00%
OneDigital Investment Advisors LLC 25,428$23,3940.00%
WELLS FARGO & COMPANY/MN 108$990.00%
NORTHERN TRUST CORP 19,617$18,0480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CANDEL THERAPEUTICS INC shareholders